SUNPHARMA

**

:** A U.S. Appellate Court affirmed the judgment in favour of Sun Pharma and its subsidiaries in the **Lipitor antitrust litigation** and also upheld the denial of class certification for plaintiffs, bringing the long-running case substantially closer to closure. **Impact:** **Positive;** reduces legal uncertainty and potential litigation-related financial risk, supporting investor sentiment.